PIM activity in tumours: A key node of therapy resistance

Publication date: Available online 22 October 2017
Source:Advances in Biological Regulation
Author(s): Richard J. Rebello, Alisée V. Huglo, Luc Furic
The PIM kinases are proto-oncogenes which have been shown to facilitate cell survival and proliferation to drive malignancy and resistance post-therapy. They are able to suppress cell death signals, sustain PI3K/AKT/mTORC1 pathway activity and regulate the MYC oncogenic program. Recent work has revealed PIM kinase essentiality for advanced tumour maintenance and described tumour sensitivity to small molecule inhibitors targeting PIM kinase in multiple malignancies.



from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2kBJQ01
via IFTTT